Pacific Biosciences of California, Inc. (PACB) Posts Q2 EPS Loss of $0.42
Tweet
Share
E-mailGet Alerts PACB Hot Sheet
Join SI Premium – FREE
Pacific Biosciences of California, Inc. (NASDAQ: PACB) reported Q2 EPS of ($0.42), $0.20 better than the analyst estimate of ($0.62). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $4.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ennis (EBF) Reports In-Line Q1 EPS
- PowerFleet, Inc. (AIOT) Misses Q1 EPS by 2c ; Offers Guidance
- Safe Bulkers (SB) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
